This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
CAMP-dependent protein kinase 3D structures
From Proteopedia
(Difference between revisions)
| Line 22: | Line 22: | ||
**[[3ag9]] - bPKA + inhibitor<br /> | **[[3ag9]] - bPKA + inhibitor<br /> | ||
**[[5n1f]], [[5n1g]], [[5n1h]], [[5n3g]], [[5n3h]], [[5n3i]], [[5n3j]], [[5n3k]], [[5n3l]], [[5n3m]], [[5n3n]], [[5n3o]], [[5n3p]], [[5n3q]], [[5n3r]], [[5n3s]], [[5n3t]] - haPKA + fragment molecule<br /> | **[[5n1f]], [[5n1g]], [[5n1h]], [[5n3g]], [[5n3h]], [[5n3i]], [[5n3j]], [[5n3k]], [[5n3l]], [[5n3m]], [[5n3n]], [[5n3o]], [[5n3p]], [[5n3q]], [[5n3r]], [[5n3s]], [[5n3t]] - haPKA + fragment molecule<br /> | ||
| - | **[[6em2]] - haPKA + | + | **[[6em2]], [[6sq1]] - haPKA + drug<br /> |
| + | **[[6snn]], [[6snx]], [[6sox]], [[6spm]], [[6sps]], [[6spu]], [[6z44]] - haPKA + benzoic acid derivative<br /> | ||
| + | **[[6spy]] - haPKA + pyridine derivative<br /> | ||
| + | **[[6zn0]] - haPKA + nicotinamide derivative<br /> | ||
**[[4ntt]] – mPKA (mutant) + ADP<br /> | **[[4ntt]] – mPKA (mutant) + ADP<br /> | ||
**[[1bkx]] – mPKA + adenosine<br /> | **[[1bkx]] – mPKA + adenosine<br /> | ||
| Line 39: | Line 42: | ||
**[[4iac]], [[4iad]], [[4iaf]], [[4iai]], [[4iak]], [[4iay]], [[4iaz]], [[4ib0]] - mPKA + PSP20 peptide<br /> | **[[4iac]], [[4iad]], [[4iaf]], [[4iai]], [[4iak]], [[4iay]], [[4iaz]], [[4ib0]] - mPKA + PSP20 peptide<br /> | ||
**[[4ib1]], [[4ib3]], [[4o22]] – mPKA + SP20 peptide<br /> | **[[4ib1]], [[4ib3]], [[4o22]] – mPKA + SP20 peptide<br /> | ||
| - | **[[6mm5]] – mPKA + | + | **[[6mm5]] – mPKA + ryanodine receptor 2 peptide<br /> |
| - | **[[6mm6]], [[6mm7]], [[6mm8]] – mPKA + | + | **[[6mm6]], [[6mm7]], [[6mm8]] – mPKA + ryanodine receptor 2 phosphorylation domain<br /> |
**[[4wb5]], [[4wb6]], [[4wb8]] – mPKA (mutant) + PKI peptide<br /> | **[[4wb5]], [[4wb6]], [[4wb8]] – mPKA (mutant) + PKI peptide<br /> | ||
**[[4wih]], [[5lcp]], [[5lcq]], [[5lcr]], [[5lct]], [[5lcu]], [[5m0u]] - haPKA + peptide inhibitor <br /> | **[[4wih]], [[5lcp]], [[5lcq]], [[5lcr]], [[5lct]], [[5lcu]], [[5m0u]] - haPKA + peptide inhibitor <br /> | ||
| + | **[[6y2u]], [[6yna]], [[6ynb]], [[6ync]], [[6ynt]], [[6ypp]], [[6yqi]], [[6yqj]], [[6yqk]] – haPKA + PKI peptide + drug<br /> | ||
| + | **[[6y0b]], [[6y2o]], [[6y89]], [[6ynr]], [[6yot]] – haPKA + PKI peptide + inhibitor<br /> | ||
*PKA catalytic subunit ternary complex | *PKA catalytic subunit ternary complex | ||
| Line 65: | Line 70: | ||
**[[5mhi]], [[5n1d]], [[5n1e]], [[5n1k]], [[5n1l]], [[5n1m]], [[5n1n]], [[5n1o]], [[5n32]], [[5n33]], [[5n36]], [[5n37]], [[5n39]], [[5n3a]], [[5n3b]], [[5n3c]], [[5n3d]], [[5n3e]], [[5n3f]], [[5n7p]], [[5n7u]] - haPKA + peptide inhibitor + fragment molecule<br /> | **[[5mhi]], [[5n1d]], [[5n1e]], [[5n1k]], [[5n1l]], [[5n1m]], [[5n1n]], [[5n1o]], [[5n32]], [[5n33]], [[5n36]], [[5n37]], [[5n39]], [[5n3a]], [[5n3b]], [[5n3c]], [[5n3d]], [[5n3e]], [[5n3f]], [[5n7p]], [[5n7u]] - haPKA + peptide inhibitor + fragment molecule<br /> | ||
**[[6f14]], [[6frx]], [[6erv]], [[6eru]], [[6ert]], [[6i2h]], [[6emd]], [[6i2b]], [[6eh3]], [[6egw]], [[5ous]], [[5ouc]], [[5oua]], [[5otg]], [[5ot3]], [[5ol3]], [[5ok3]], [[5o5m]], [[5o0e]], [[5nw8]], [[5ntj]] - haPKA + peptide inhibitor + inhibitor<br /> | **[[6f14]], [[6frx]], [[6erv]], [[6eru]], [[6ert]], [[6i2h]], [[6emd]], [[6i2b]], [[6eh3]], [[6egw]], [[5ous]], [[5ouc]], [[5oua]], [[5otg]], [[5ot3]], [[5ol3]], [[5ok3]], [[5o5m]], [[5o0e]], [[5nw8]], [[5ntj]] - haPKA + peptide inhibitor + inhibitor<br /> | ||
| - | **[[6erw]], [[6ers]], [[6emb]], [[5m75]], [[5m71]], [[5m6y]], [[5m6v]], [[5m0l]], [[5m0c]], [[5m0b]] - haPKA + peptide inhibitor + | + | **[[6erw]], [[6ers]], [[6emb]], [[5m75]], [[5m71]], [[5m6y]], [[5m6v]], [[5m0l]], [[5m0c]], [[5m0b]] - haPKA + peptide inhibitor + drug<br /> |
| - | **[[6i2a]] - haPKA + RPK153 + | + | **[[6i2a]] - haPKA + RPK153 + drug <br /> |
| - | **[[6i2c]], [[6i2d]] - haPKA + RPK182 + | + | **[[6i2c]], [[6i2d]] - haPKA + RPK182 + drug <br /> |
*PKA catalytic subunit ternary complex with nucleotide | *PKA catalytic subunit ternary complex with nucleotide | ||
| Line 81: | Line 86: | ||
**[[6esa]] - haPKA + peptide inhibitor + ribose + AMP<br /> | **[[6esa]] - haPKA + peptide inhibitor + ribose + AMP<br /> | ||
**[[6ema]] - haPKA + peptide inhibitor + inhibitor + ATP<br /> | **[[6ema]] - haPKA + peptide inhibitor + inhibitor + ATP<br /> | ||
| + | **[[6y8c]] – haPKA + PKI peptide + ATP<br /> | ||
| + | **[[6y05]] – haPKA + PKI peptide + Adenine<br /> | ||
| - | *PKA regulatory subunit | + | *'''PKA regulatory subunit''' |
**[[4f9k]] – hPKA I-β<br /> | **[[4f9k]] – hPKA I-β<br /> | ||
| Line 92: | Line 99: | ||
**[[1r2a]] - mPKA II dimerization-anchoring domain – NMR<br /> | **[[1r2a]] - mPKA II dimerization-anchoring domain – NMR<br /> | ||
**[[1l6e]] - mPKA II-α dimerization-anchoring domain – NMR<br /> | **[[1l6e]] - mPKA II-α dimerization-anchoring domain – NMR<br /> | ||
| - | **[[3of1]] - yPKA <br /> | + | **[[3of1]], [[6xqk]] - yPKA <br /> |
*PKA regulatory subunit binary complex | *PKA regulatory subunit binary complex | ||
| Line 108: | Line 115: | ||
**[[5t3n]] - PfPKA + cAMP derivative – ''Plasmodium falciparum''<br /> | **[[5t3n]] - PfPKA + cAMP derivative – ''Plasmodium falciparum''<br /> | ||
**[[5kbf]], [[5k8s]] - PfPKA + cAMP <br /> | **[[5kbf]], [[5k8s]] - PfPKA + cAMP <br /> | ||
| + | **[[6h4g]] - PKA (mutant) + cAMP – ''Trypanosoma brucei''<br /> | ||
| + | **[[6rsx]] - PKA + cAMP – ''Euglena gracilis''<br /> | ||
*PKA regulatory subunit ternary complex | *PKA regulatory subunit ternary complex | ||
Revision as of 07:10, 24 May 2021
3D structures of cAMP-dependent protein kinase
Updated on 24-May-2021
